Clinical Distribution and Drug Resistance of 4 Non-Fermenting Bacteria of Lower Respiratory Tract Infection

Jianying Zhang

2011-01-01

Abstract:Objective To understand the lower respiratory tract infections by 4 non-fermenting bacteria and their drug resistance and clinical distribution.Method A retrospective survey method was used to analyze the antimicrobial susceptibility and clinical distribution of 4 non-fermenting bacteria isolated from patients with lower respiratory tract infection in the Respiratory Medicine department and ICUs of our hospital during June 2007 to December 2009.Result A total of 393 target strains were isolated,including Acinetobacter baumannii(152 strains),Pseudomonas aeruginosa(127 strains),Stenotrophomonas maltophilia(73 strains),and Burkholderia cepacia bacteria(41 strains);The primary disease from which the highest number of isolates were obtained was chronic obstructive pulmonary disease(24.4%),followed by primary lung cancer(16.5%),bronchiectasis(14.8%) and pneumonia(12.2%).Susceptibility test revealed that the 4 kinds of non-fermentative bacteria tend to be multi-drug resistant,with the resistance rates to ampicillin/sulbactam,gentamicin and piperacillin 50%,and to Imipenem and meropenem 37.8%;The lowest resistance rates were against cefoperazone/sulbactam and piperacillin/tazobactam,with the ranges of 14.2% to 26.8% and 25.2% to 50.7%,respectively.Conclusion Lower respiratory tract specimens were non-fermentative bacteria isolated mainly from hospitalized patients with 9 kinds of diseases,such as COPD and primary lung cancer.These patients are susceptible to nosocomial infection and should be closely monitored.In vitro susceptibility testing shows that the drug resistance of the four kinds of non-fermenting bacteria is very serious,and information on changes in drug resistance should be announced regularly to develop and improve preventive measures,so as to reduce nosocomial infection rate and the bacterial resistance rate.